We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

Cancer Research Horizons: Driving Innovation and Strengthening Academia–Industry Collaboration
Industry Insight

Cancer Research Horizons: Driving Innovation and Strengthening Academia–Industry Collaboration

In April 2022, Cancer Research UK unveiled Cancer Research Horizons, its new approach to driving innovation in the field. Technology Networks had the opportunity to speak with two members of Cancer Research Horizon’s executive leadership team to learn more about some of the cutting-edge experimental capabilities that will be used to interrogate cancer biology more thoroughly.
20 Years On: The Evolution of HPC
Industry Insight

20 Years On: The Evolution of HPC

This article takes a look at the incredible transformation high performance computing has experience over the past few years.
Molecular Spectroscopy Evolves To Meet Changing Pharma and Biopharma Needs
Industry Insight

Molecular Spectroscopy Evolves To Meet Changing Pharma and Biopharma Needs

We spoke to Geoff Winkett and Michel van den Berge from Agilent, about the concerns they hear from their customers in the pharmaceutical and biopharmaceutical sector and how they are helping to address them.
Developing a Sustainable Source of Squalene
Industry Insight

Developing a Sustainable Source of Squalene

Technology Networks spoke to Jason Ornstein and Barry Holtz to learn how Synshark and Phylloceuticals are working together to address current challenges associated with squalene supply and access.

Enzymatic Approaches Promise To Bring DNA Synthesis Back to Labs
Industry Insight

Enzymatic Approaches Promise To Bring DNA Synthesis Back to Labs

In this opinion piece, Dan Gibson discusses some of the common pitfalls in the DNA synthesis field and explores how a new generation of synthesis technologies could overcome these challenges.
Behind the Scenes on the First Study To Compare the Effects of LSD and Psilocybin
Industry Insight

Behind the Scenes on the First Study To Compare the Effects of LSD and Psilocybin

A new study has compared the effects of varied doses of psilocybin and LSD for the first time. These two popular psychedelics have been of increasing interest in clinical research. Technology Networks caught up with Rob Barrow, CEO of MindMed, to discuss the findings in more detail and explore pressing issues around blinding in psychedelic drug development.


Treating <i>C. diff</i> Infection and More With Gut Microbiome Transplants
Industry Insight

Treating C. diff Infection and More With Gut Microbiome Transplants

Technology Networks had the pleasure of speaking to Thomas Lendvay, CMO and co-founder of Tend about the current applications of gut microbiota transplants and how they could be used in future.
OPC UA for Sample Process Automation – Improving Data Harmonization for Biobanks and Cell and Gene Therapies
Industry Insight

OPC UA for Sample Process Automation – Improving Data Harmonization for Biobanks and Cell and Gene Therapies

Technology Networks had the pleasure of talking to Wilfredo Marín to learn more about OPC UA and how it is suited to biobanking and cell and gene therapy development.
Digital Evolution: How Computer Science and AI Are Driving Microscopy Innovation and Advancing Life Sciences
Industry Insight

Digital Evolution: How Computer Science and AI Are Driving Microscopy Innovation and Advancing Life Sciences

This article explores how automated tools are helping researchers to algorithmically “unmix” spectral ranges – producing faster, smarter and higher-quality data and providing new possibilities for interpreting image data.
Keeping Up With the Drive for Microplastics Detection
Industry Insight

Keeping Up With the Drive for Microplastics Detection

We spoke to Geoff Winkett and Michel van den Berge from Agilent, about the issues posed by microplastics analyses and how molecular spectroscopy is rising to the challenge.
Advertisement